Lataa...
Biological therapy for ulcerative colitis: An update
Of the diverse biological agents used for patients with ulcerative colitis, the anti-tumor necrosis factor-α agents infliximab and adalimumab have been used in large-scale clinical trials and are currently widely used in the treatment of inflammatory bowel disease patients. Recent studies have indic...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4188881/ https://ncbi.nlm.nih.gov/pubmed/25309060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i37.13234 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|